Financial Sense Advisors Inc. Sells 65,966 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Financial Sense Advisors Inc. cut its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 32.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 138,323 shares of the pharmacy operator's stock after selling 65,966 shares during the period. Financial Sense Advisors Inc.'s holdings in Walgreens Boots Alliance were worth $1,291,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. State Street Corp boosted its holdings in Walgreens Boots Alliance by 18.0% in the third quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator's stock worth $385,258,000 after acquiring an additional 6,569,223 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in Walgreens Boots Alliance by 43.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator's stock worth $98,284,000 after acquiring an additional 3,329,857 shares in the last quarter. Two Sigma Advisers LP bought a new stake in Walgreens Boots Alliance in the third quarter worth $24,226,000. Thompson Siegel & Walmsley LLC lifted its holdings in shares of Walgreens Boots Alliance by 15.5% during the third quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator's stock valued at $62,325,000 after purchasing an additional 934,754 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Walgreens Boots Alliance by 12.1% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator's stock valued at $68,046,000 after purchasing an additional 817,762 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

WBA has been the topic of a number of research analyst reports. Bank of America upped their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a report on Monday, January 13th. Evercore ISI upped their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an "in-line" rating in a report on Monday, January 13th. Truist Financial lowered their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a report on Friday, January 31st. Finally, Royal Bank of Canada upped their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a report on Wednesday, January 15th. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company. According to MarketBeat, Walgreens Boots Alliance has an average rating of "Hold" and an average price target of $12.63.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ:WBA traded down $0.21 during trading on Friday, hitting $10.31. 8,729,355 shares of the company's stock were exchanged, compared to its average volume of 26,545,848. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $22.05. The business's 50-day simple moving average is $10.38 and its 200 day simple moving average is $9.72. The company has a market cap of $8.91 billion, a price-to-earnings ratio of -1.01, a PEG ratio of 1.35 and a beta of 0.65.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating analysts' consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. During the same period in the prior year, the company earned $0.66 earnings per share. The firm's revenue was up 7.6% on a year-over-year basis. As a group, equities analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.